Anti-GFRA3 Antibody (Nadecnemab)
Catalog No.
F2029
Anti-GFRA3 Antibody (Nadecnemab)
Featured Products
Nadecnemab is an IgG4κ antibody targeting GFRA3, a member of the glial cell line-derived neurotrophic factor family of receptors. Nadecnemab is indicated for the treatment of knee osteoarthritis/pain.
145 kDa
Dry ice
2377679-19-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
REGN5069, REGN-5069, REGN 5069
100 mM Pro 20 mM Arg pH 5.0. No preservative!
O60609
Human
Unconjugated
Monoclonal
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
GFRA3
Please avoid freeze-thaw cycles.